1. Home
  2. KALA vs IZEA Comparison

KALA vs IZEA Comparison

Compare KALA & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • IZEA
  • Stock Information
  • Founded
  • KALA 2009
  • IZEA 2006
  • Country
  • KALA United States
  • IZEA United States
  • Employees
  • KALA N/A
  • IZEA N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • KALA Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • KALA 26.2M
  • IZEA 29.1M
  • IPO Year
  • KALA 2017
  • IZEA N/A
  • Fundamental
  • Price
  • KALA $5.10
  • IZEA $2.61
  • Analyst Decision
  • KALA Strong Buy
  • IZEA
  • Analyst Count
  • KALA 3
  • IZEA 0
  • Target Price
  • KALA $14.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • KALA 71.3K
  • IZEA 39.3K
  • Earning Date
  • KALA 08-05-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • KALA N/A
  • IZEA N/A
  • EPS Growth
  • KALA N/A
  • IZEA N/A
  • EPS
  • KALA N/A
  • IZEA N/A
  • Revenue
  • KALA N/A
  • IZEA $36,896,490.00
  • Revenue This Year
  • KALA N/A
  • IZEA $22.24
  • Revenue Next Year
  • KALA N/A
  • IZEA N/A
  • P/E Ratio
  • KALA N/A
  • IZEA N/A
  • Revenue Growth
  • KALA N/A
  • IZEA 7.17
  • 52 Week Low
  • KALA $2.92
  • IZEA $1.68
  • 52 Week High
  • KALA $11.20
  • IZEA $3.15
  • Technical
  • Relative Strength Index (RSI)
  • KALA 62.32
  • IZEA 47.64
  • Support Level
  • KALA $4.36
  • IZEA $2.54
  • Resistance Level
  • KALA $5.90
  • IZEA $2.76
  • Average True Range (ATR)
  • KALA 0.50
  • IZEA 0.14
  • MACD
  • KALA 0.07
  • IZEA -0.03
  • Stochastic Oscillator
  • KALA 61.50
  • IZEA 31.52

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: